Merck's Q1 Earnings Growth Will Likely Be Led By Higher Keytruda Sales - Forbes

Merck's Q1 Earnings Growth Will Likely Be Led By Higher Keytruda Sales  Forbes

Merck (NYSE:MRK) is expected to publish its Q1 2019 results on April 30. This note details Trefis' forecasts for Merck, as well as some of the key trends we will ...



Comments

Popular posts from this blog

Types of skin cancer and how to spot them - Jersey's Best

What to do about skin tags, moles and other bumps - The Washington Post

STIs With Flu-Like Symptoms